Global Sentinel Lymph Node Biopsy Imaging Agents Market Size & Outlook
Global sentinel lymph node biopsy imaging agents market, 2021-2033 (US$M)
Related Markets
Global sentinel lymph node biopsy imaging agents market highlights
- The global sentinel lymph node biopsy imaging agents market generated a revenue of USD 2,175.2 million in 2025 and is expected to reach USD 2,425.9 million by 2033.
- The market is expected to grow at a CAGR (2026 - 2033) of 1.4% by 2033.
- In terms of segment, radioactive tracers accounted for a revenue of USD 51.0 million in 2025.
- Fluorescent Imaging Agents is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, Europe was the largest revenue generating market in 2025.
- Country-wise, U.S. is expected to register the highest CAGR from 2026 to 2033.
Global data book summary
| Market revenue in 2025 | USD 2,175.2 million |
| Market revenue in 2033 | USD 2,425.9 million |
| Growth rate | 1.4% (CAGR from 2026 to 2033) |
| Largest segment | Radioactive tracers |
| Fastest growing segment | Fluorescent Imaging Agents |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Radioactive Tracers, Dye-Based Agents, Fluorescent Imaging Agents |
Other key industry trends
- In terms of revenue, the North America accounted for 15.2% of the global sentinel lymph node biopsy imaging agents market in 2025.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, U.S. is the fastest growing regional market and is projected to reach USD 188.3 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sentinel Lymph Node Biopsy Imaging Agents Market Scope
Sentinel Lymph Node Biopsy Imaging Agents Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | View profile | - | - | - |
| Jubilant Pharmova | View profile | 10001+ | Noida, Uttar Pradesh, India, Asia | https://www.jubilantpharmova.com |
| Guerbet | View profile | 501-1000 | Villepinte, Languedoc-Roussillon, France, Europe | http://www.guerbet.com |
| Curium Pharma | View profile | 1001-5000 | Paris, Ile-de-France, France, Europe | https://www.curiumpharma.com/contact/ |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| Hologic Inc | View profile | 6990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | http://www.hologic.com |
| Cardinal Health Inc | View profile | 48000 | 7000 Cardinal Place, Dublin, OH, United States, 43017 | https://www.cardinalhealth.com |
| GE HealthCare Technologies Inc Common Stock | View profile | 51000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | https://www.gehealthcare.com |
Global sentinel lymph node biopsy imaging agents market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to sentinel lymph node biopsy imaging agents market will help companies and investors design strategic landscapes.
Radioactive tracers was the largest segment with a revenue share of 2.34% in 2025. Horizon Databook has segmented the Global sentinel lymph node biopsy imaging agents market based on radioactive tracers, dye-based agents, fluorescent imaging agents covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Sentinel Lymph Node Biopsy Imaging Agents Product Outlook (Revenue, USD Million, 2021-2033)
- Radioactive Tracers
- Technetium-99m Sulfur Colloid
- Technetium-99m Nanocolloid
- Tilmanocept (Lymphoseek)
- Others Radioactive Tracers
- Dye-Based Agents
- Isosulfan Blue
- Patent Blue V
- Methylene Blue
- Fluorescent Imaging Agents
- Others
- Radioactive Tracers
- Global Sentinel Lymph Node Biopsy Imaging Agents Application Outlook (Revenue, USD Million, 2021-2033)
- Breast Cancer
- Melanoma
- Head & Neck Cancer
- Gynecological Cancers
- Other Indications
- Global Sentinel Lymph Node Biopsy Imaging Agents Procedure Type Outlook (Revenue, USD Million, 2021-2033)
- Open Surgery
- Minimally Invasive Surgery
- Global Sentinel Lymph Node Biopsy Imaging Agents End Use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Cancer Specialty Clinics
Reasons to subscribe to Global sentinel lymph node biopsy imaging agents market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global sentinel lymph node biopsy imaging agents market databook
-
Our clientele includes a mix of sentinel lymph node biopsy imaging agents market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global sentinel lymph node biopsy imaging agents market , including forecasts for subscribers. This global databook contains high-level insights into Global sentinel lymph node biopsy imaging agents market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global sentinel lymph node biopsy imaging agents market size, by regions, 2021-2033 (US$M)
Top 10 countries: Sentinel lymph node biopsy imaging agents market size, 2025 (US$M)
Global sentinel lymph node biopsy imaging agents market share, by product, 2025 & 2033 (%, US$M)
Sentinel lymph node biopsy imaging agents market: Opportunity assessment by country
Global sentinel lymph node biopsy imaging agents market, by region, 2025 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
